NEOGEN2024-04-012024-06-30 NEOGEN2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member NEOGEN2024-06-30 NEOGEN2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 542665 NEOGEN NOTLISTED Neogen Chemicals Limited Equity 2024-04-01 2025-03-31 2024-08-07 2024-08-01 INR Crores First quarter 17:00:00 21:45:00 2024-08-07 2024-08-07 Not applicable Single segment Specialty Chemicals 2024-04-01 2024-06-30 Unaudited Consolidated 1799500000.00 15700000.00 1815200000.00 1017700000.00 0.00 -53900000.00 160100000.00 98200000.00 68100000.00 367600000.00 1657800000.00 157400000.00 0.00 157400000.00 36300000.00 6600000.00 42900000.00 0.00 114500000.00 0.00 0.00 0.00 200000.00 114700000.00 -1300000.00 113400000.00 0.00 0.00 0.00 0.00 263800000.00 10 4.35 4.35 0.00 0.00 4.35 4.35 1. The above unaudited financial results of the Company for the quarter ended June 30, 2024 have been prepared in accordance with the IND AS, as prescribed under section 133 of the Companies Act, 2013 read with the Companies (Indian Accounting Standards) Rules, 2015 and the other accounting principles generally accepted in India and were reviewed by the Statutory Auditor and recommended by the Audit Committee in its meeting held on August 7, 2024 and was approved by the Board of Directors at their meeting held on August 7, 2024. 2. The unaudited financial results of Dhara Finechem Industries (a joint venture where the Company is holding 90% of the capital contribution), the wholly owned subsidiaries of the Company namely Neogen Ionics Limited and Buli Chemicals India Private Limited for the quarter ended June 30, 2024 is considered for Unaudited Consolidated Financial Results. 3. Previous period / year's figures have been regrouped/rearranged wherever necessary to make them comparable. 4. The figures for the quarter ended March 31, 2024 are balancing figures between the audited figures in respect of the full financial year and the published year to date unaudited figures for the nine-month period ended December 31, 2023, which were subjected to limited review. 5. The company is in the business of manufacturing specialty chemicals and accordingly has one reportable business segment. 6. The above is an extract of the detailed format of Quarterly Financial Results filed with Stock Exchanges under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The full format of the unaudited results for the quarter ended June 30, 2024 are available at the Company's website at https://neogenchem.com/financial-performance/ and Stock Exchange's website at www.nseindia.com and www.bseindia.com. Other Expenses 367600000.00 Items that will not be re-classified to profit or loss -1800000.00 -1800000.00 -500000.00 0.00